David J Nikolic-Paterson Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

1/2006	Recent insights into experimental mouse models of diabetic nephropathy.
6/2005	Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Nikolic-Paterson Research Topics

Disease

48	Fibrosis (Cirrhosis) 04/2024 - 01/2004
27	Inflammation (Inflammations) 01/2023 - 09/2002
19	Glomerulonephritis 02/2018 - 07/2000
17	Proteinuria 01/2024 - 07/2000
17	Kidney Diseases (Kidney Disease) 10/2020 - 06/2003
9	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019 - 01/2004
9	Nephritis 01/2019 - 01/2003
8	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2010
7	Chronic Renal Insufficiency 12/2020 - 09/2014
7	Albuminuria 01/2018 - 01/2004
6	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 02/2018 - 01/2003
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2023 - 01/2008
4	Necrosis 03/2024 - 01/2014
3	Reperfusion Injury 03/2024 - 01/2016
3	Hypertrophy 01/2019 - 12/2008
3	Thrombosis (Thrombus) 01/2018 - 12/2011
3	Disease Progression 03/2016 - 04/2009
3	Hyperglycemia 02/2008 - 01/2004
3	Obesity 01/2006 - 01/2004
2	Sclerosis 01/2024 - 01/2002
2	Ureteral Obstruction 01/2023 - 02/2007
2	Balkan Nephropathy (Balkan Endemic Nephropathy) 10/2021 - 01/2021
2	Emphysema 02/2018 - 05/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2018 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2006 - 06/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2006 - 06/2005
1	Segmental glomerulosclerosis 01/2024
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2024
1	Neoplasms (Cancer) 01/2023
1	Animal Disease Models 01/2022
1	Renal Insufficiency (Renal Failure) 01/2021
1	Lupus Nephritis 01/2021

Drug/Important Bio-Agent (IBA)

17	CollagenIBA 01/2018 - 02/2004
13	p38 Mitogen-Activated Protein KinasesIBA 10/2020 - 02/2003
10	Phosphotransferases (Kinase)IBA 01/2021 - 01/2009
9	JNK Mitogen-Activated Protein KinasesIBA 01/2022 - 02/2007
8	antiglomerular basement membrane antibodyIBA 02/2018 - 01/2003
8	CytokinesIBA 09/2014 - 07/2000
7	Messenger RNA (mRNA)IBA 05/2012 - 02/2003
5	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2020 - 11/2014
5	EnzymesIBA 02/2018 - 01/2002
5	Syk KinaseIBA 01/2018 - 12/2011
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 09/2002
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2004
4	aristolochic acid I (aristolochic acid)IBA 01/2022 - 03/2016
4	SteroidsIBA 01/2021 - 07/2006
4	Matrix Metalloproteinases (MMPs)IBA 02/2018 - 12/2011
4	Streptozocin (Streptozotocin)FDA Link 01/2018 - 12/2004
4	Macrophage Migration-Inhibitory FactorsIBA 02/2014 - 01/2002
4	Immunoglobulin G (IgG)IBA 01/2014 - 01/2003
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2010 - 02/2004
3	mizoribineIBA 01/2023 - 04/2008
3	4- (9- (tetrahydrofuran- 3- yl))- 8- (2,4,6- trifluorophenylamino)- 9H- purin- 2- ylaminocyclohexan- 1- olIBA 01/2021 - 01/2011
3	MAP Kinase Kinase Kinase 5IBA 10/2020 - 01/2016
3	GS-444217IBA 10/2018 - 11/2015
3	AlbuminsIBA 01/2018 - 02/2004
3	Protein Isoforms (Isoforms)IBA 01/2016 - 12/2003
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 01/2013
3	AntigensIBA 11/2014 - 01/2003
3	Macrophage Colony-Stimulating FactorIBA 07/2011 - 09/2002
3	CC 401IBA 09/2010 - 02/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 10/2009 - 10/2004
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 01/2019
2	Cyclophilin AIBA 12/2020 - 05/2020
2	Cyclophilins (Cyclophilin)IBA 12/2020 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2019 - 10/2018
2	ChemokinesIBA 09/2019 - 01/2004
2	TOR Serine-Threonine KinasesIBA 01/2019 - 01/2014
2	Extracellular Matrix ProteinsIBA 02/2018 - 05/2012
2	Serum AlbuminIBA 01/2018 - 02/2004
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2014 - 01/2004
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2014 - 07/2006
2	resolvin D1IBA 01/2013 - 01/2013
2	LipidsIBA 01/2013 - 12/2012
2	Interleukin-10 (Interleukin 10)IBA 05/2012 - 02/2003
2	Transcription Factors (Transcription Factor)IBA 06/2011 - 07/2000
2	nephrinIBA 01/2011 - 11/2008
2	NPHS2 proteinIBA 01/2011 - 11/2008
2	Immunoglobulin A (IgA)IBA 01/2011 - 01/2002
2	GlucocorticoidsIBA 01/2010 - 12/2005
2	Prednisolone (Predate)FDA LinkGeneric 01/2010 - 04/2008
2	Insulin (Novolin)FDA Link 04/2008 - 02/2008
2	Cell Adhesion MoleculesIBA 06/2005 - 07/2000
2	Blood Glucose (Blood Sugar)IBA 12/2004 - 01/2004
2	CreatinineIBA 12/2004 - 01/2004
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Antisense OligonucleotidesIBA 04/2024
1	Peptides (Polypeptides)IBA 04/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	OligonucleotidesIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	CalcineurinIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	InflammasomesIBA 01/2020
1	Transcription Factor Brn-3AIBA 01/2020
1	ginsenoside M1IBA 01/2020
1	Sirtuin 1IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2024 - 01/2004
1	Immunotherapy 01/2023